Microbial Alternative Protein Market
1 Study Coverage
1.1 Microbial Alternative Protein Product Introduction
1.2 Market by Type
1.2.1 Global Microbial Alternative Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Emerging Alternative Protein
1.2.3 Adolescent Alternative Protein
1.2.4 Matured Alternative Protein
1.3 Market by Application
1.3.1 Global Microbial Alternative Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microbial Alternative Protein Sales Estimates and Forecasts 2017-2028
2.2 Global Microbial Alternative Protein Revenue Estimates and Forecasts 2017-2028
2.3 Global Microbial Alternative Protein Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microbial Alternative Protein Sales by Region
2.4.1 Global Microbial Alternative Protein Sales by Region (2017-2022)
2.4.2 Global Sales Microbial Alternative Protein by Region (2023-2028)
2.5 Global Microbial Alternative Protein Revenue by Region
2.5.1 Global Microbial Alternative Protein Revenue by Region (2017-2022)
2.5.2 Global Microbial Alternative Protein Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microbial Alternative Protein Sales by Manufacturers
3.1.1 Global Top Microbial Alternative Protein Manufacturers by Sales (2017-2022)
3.1.2 Global Microbial Alternative Protein Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microbial Alternative Protein in 2021
3.2 Global Microbial Alternative Protein Revenue by Manufacturers
3.2.1 Global Microbial Alternative Protein Revenue by Manufacturers (2017-2022)
3.2.2 Global Microbial Alternative Protein Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microbial Alternative Protein Revenue in 2021
3.3 Global Microbial Alternative Protein Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microbial Alternative Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microbial Alternative Protein Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microbial Alternative Protein Sales by Type
4.1.1 Global Microbial Alternative Protein Historical Sales by Type (2017-2022)
4.1.2 Global Microbial Alternative Protein Forecasted Sales by Type (2023-2028)
4.1.3 Global Microbial Alternative Protein Sales Market Share by Type (2017-2028)
4.2 Global Microbial Alternative Protein Revenue by Type
4.2.1 Global Microbial Alternative Protein Historical Revenue by Type (2017-2022)
4.2.2 Global Microbial Alternative Protein Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
4.3 Global Microbial Alternative Protein Price by Type
4.3.1 Global Microbial Alternative Protein Price by Type (2017-2022)
4.3.2 Global Microbial Alternative Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microbial Alternative Protein Sales by Application
5.1.1 Global Microbial Alternative Protein Historical Sales by Application (2017-2022)
5.1.2 Global Microbial Alternative Protein Forecasted Sales by Application (2023-2028)
5.1.3 Global Microbial Alternative Protein Sales Market Share by Application (2017-2028)
5.2 Global Microbial Alternative Protein Revenue by Application
5.2.1 Global Microbial Alternative Protein Historical Revenue by Application (2017-2022)
5.2.2 Global Microbial Alternative Protein Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
5.3 Global Microbial Alternative Protein Price by Application
5.3.1 Global Microbial Alternative Protein Price by Application (2017-2022)
5.3.2 Global Microbial Alternative Protein Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microbial Alternative Protein Market Size by Type
6.1.1 North America Microbial Alternative Protein Sales by Type (2017-2028)
6.1.2 North America Microbial Alternative Protein Revenue by Type (2017-2028)
6.2 North America Microbial Alternative Protein Market Size by Application
6.2.1 North America Microbial Alternative Protein Sales by Application (2017-2028)
6.2.2 North America Microbial Alternative Protein Revenue by Application (2017-2028)
6.3 North America Microbial Alternative Protein Market Size by Country
6.3.1 North America Microbial Alternative Protein Sales by Country (2017-2028)
6.3.2 North America Microbial Alternative Protein Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Microbial Alternative Protein Market Size by Type
7.1.1 Europe Microbial Alternative Protein Sales by Type (2017-2028)
7.1.2 Europe Microbial Alternative Protein Revenue by Type (2017-2028)
7.2 Europe Microbial Alternative Protein Market Size by Application
7.2.1 Europe Microbial Alternative Protein Sales by Application (2017-2028)
7.2.2 Europe Microbial Alternative Protein Revenue by Application (2017-2028)
7.3 Europe Microbial Alternative Protein Market Size by Country
7.3.1 Europe Microbial Alternative Protein Sales by Country (2017-2028)
7.3.2 Europe Microbial Alternative Protein Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microbial Alternative Protein Market Size by Type
8.1.1 Asia Pacific Microbial Alternative Protein Sales by Type (2017-2028)
8.1.2 Asia Pacific Microbial Alternative Protein Revenue by Type (2017-2028)
8.2 Asia Pacific Microbial Alternative Protein Market Size by Application
8.2.1 Asia Pacific Microbial Alternative Protein Sales by Application (2017-2028)
8.2.2 Asia Pacific Microbial Alternative Protein Revenue by Application (2017-2028)
8.3 Asia Pacific Microbial Alternative Protein Market Size by Region
8.3.1 Asia Pacific Microbial Alternative Protein Sales by Region (2017-2028)
8.3.2 Asia Pacific Microbial Alternative Protein Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Microbial Alternative Protein Market Size by Type
9.1.1 Latin America Microbial Alternative Protein Sales by Type (2017-2028)
9.1.2 Latin America Microbial Alternative Protein Revenue by Type (2017-2028)
9.2 Latin America Microbial Alternative Protein Market Size by Application
9.2.1 Latin America Microbial Alternative Protein Sales by Application (2017-2028)
9.2.2 Latin America Microbial Alternative Protein Revenue by Application (2017-2028)
9.3 Latin America Microbial Alternative Protein Market Size by Country
9.3.1 Latin America Microbial Alternative Protein Sales by Country (2017-2028)
9.3.2 Latin America Microbial Alternative Protein Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Microbial Alternative Protein Market Size by Type
10.1.1 Middle East and Africa Microbial Alternative Protein Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microbial Alternative Protein Revenue by Type (2017-2028)
10.2 Middle East and Africa Microbial Alternative Protein Market Size by Application
10.2.1 Middle East and Africa Microbial Alternative Protein Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microbial Alternative Protein Revenue by Application (2017-2028)
10.3 Middle East and Africa Microbial Alternative Protein Market Size by Country
10.3.1 Middle East and Africa Microbial Alternative Protein Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microbial Alternative Protein Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AgriProtein (South Africa)
11.1.1 AgriProtein (South Africa) Corporation Information
11.1.2 AgriProtein (South Africa) Overview
11.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AgriProtein (South Africa) Recent Developments
11.2 Ynsect (France)
11.2.1 Ynsect (France) Corporation Information
11.2.2 Ynsect (France) Overview
11.2.3 Ynsect (France) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ynsect (France) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ynsect (France) Recent Developments
11.3 Enterra Feed Corporation (Canada)
11.3.1 Enterra Feed Corporation (Canada) Corporation Information
11.3.2 Enterra Feed Corporation (Canada) Overview
11.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Enterra Feed Corporation (Canada) Recent Developments
11.4 Protix (The Netherlands)
11.4.1 Protix (The Netherlands) Corporation Information
11.4.2 Protix (The Netherlands) Overview
11.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Protix (The Netherlands) Recent Developments
11.5 Proti-Farm Holding NV (The Netherlands)
11.5.1 Proti-Farm Holding NV (The Netherlands) Corporation Information
11.5.2 Proti-Farm Holding NV (The Netherlands) Overview
11.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments
11.6 Entomo Farms (Canada)
11.6.1 Entomo Farms (Canada) Corporation Information
11.6.2 Entomo Farms (Canada) Overview
11.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Entomo Farms (Canada) Recent Developments
11.7 Global Bugs Asia Co., Ltd. (Thailand)
11.7.1 Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
11.7.2 Global Bugs Asia Co., Ltd. (Thailand) Overview
11.7.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments
11.8 Aspire Food Group (U.S.)
11.8.1 Aspire Food Group (U.S.) Corporation Information
11.8.2 Aspire Food Group (U.S.) Overview
11.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aspire Food Group (U.S.) Recent Developments
11.9 Tiny Farms (U.S.)
11.9.1 Tiny Farms (U.S.) Corporation Information
11.9.2 Tiny Farms (U.S.) Overview
11.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tiny Farms (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microbial Alternative Protein Industry Chain Analysis
12.2 Microbial Alternative Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microbial Alternative Protein Production Mode & Process
12.4 Microbial Alternative Protein Sales and Marketing
12.4.1 Microbial Alternative Protein Sales Channels
12.4.2 Microbial Alternative Protein Distributors
12.5 Microbial Alternative Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microbial Alternative Protein Industry Trends
13.2 Microbial Alternative Protein Market Drivers
13.3 Microbial Alternative Protein Market Challenges
13.4 Microbial Alternative Protein Market Restraints
14 Key Findings in The Global Microbial Alternative Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Microbial Alternative Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Emerging Alternative Protein
Table 3. Major Manufacturers of Adolescent Alternative Protein
Table 4. Major Manufacturers of Matured Alternative Protein
Table 5. Global Microbial Alternative Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Microbial Alternative Protein Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Microbial Alternative Protein Sales by Region (2017-2022) & (Kiloton)
Table 8. Global Microbial Alternative Protein Sales Market Share by Region (2017-2022)
Table 9. Global Microbial Alternative Protein Sales by Region (2023-2028) & (Kiloton)
Table 10. Global Microbial Alternative Protein Sales Market Share by Region (2023-2028)
Table 11. Global Microbial Alternative Protein Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Microbial Alternative Protein Revenue Market Share by Region (2017-2022)
Table 13. Global Microbial Alternative Protein Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Microbial Alternative Protein Revenue Market Share by Region (2023-2028)
Table 15. Global Microbial Alternative Protein Sales by Manufacturers (2017-2022) & (Kiloton)
Table 16. Global Microbial Alternative Protein Sales Share by Manufacturers (2017-2022)
Table 17. Global Microbial Alternative Protein Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Microbial Alternative Protein Revenue Share by Manufacturers (2017-2022)
Table 19. Microbial Alternative Protein Price by Manufacturers (2017-2022) &(US$/Ton)
Table 20. Global Microbial Alternative Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Microbial Alternative Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Alternative Protein as of 2021)
Table 22. Microbial Alternative Protein Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Microbial Alternative Protein Product Offered
Table 24. Date of Manufacturers Enter into Microbial Alternative Protein Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 27. Global Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 28. Global Microbial Alternative Protein Sales Share by Type (2017-2022)
Table 29. Global Microbial Alternative Protein Sales Share by Type (2023-2028)
Table 30. Global Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Microbial Alternative Protein Revenue Share by Type (2017-2022)
Table 33. Global Microbial Alternative Protein Revenue Share by Type (2023-2028)
Table 34. Microbial Alternative Protein Price by Type (2017-2022) & (US$/Ton)
Table 35. Global Microbial Alternative Protein Price Forecast by Type (2023-2028) & (US$/Ton)
Table 36. Global Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 37. Global Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 38. Global Microbial Alternative Protein Sales Share by Application (2017-2022)
Table 39. Global Microbial Alternative Protein Sales Share by Application (2023-2028)
Table 40. Global Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Microbial Alternative Protein Revenue Share by Application (2017-2022)
Table 43. Global Microbial Alternative Protein Revenue Share by Application (2023-2028)
Table 44. Microbial Alternative Protein Price by Application (2017-2022) & (US$/Ton)
Table 45. Global Microbial Alternative Protein Price Forecast by Application (2023-2028) & (US$/Ton)
Table 46. North America Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 47. North America Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 48. North America Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 51. North America Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 52. North America Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Microbial Alternative Protein Sales by Country (2017-2022) & (Kiloton)
Table 55. North America Microbial Alternative Protein Sales by Country (2023-2028) & (Kiloton)
Table 56. North America Microbial Alternative Protein Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Microbial Alternative Protein Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 59. Europe Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 60. Europe Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 63. Europe Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 64. Europe Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Microbial Alternative Protein Sales by Country (2017-2022) & (Kiloton)
Table 67. Europe Microbial Alternative Protein Sales by Country (2023-2028) & (Kiloton)
Table 68. Europe Microbial Alternative Protein Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Microbial Alternative Protein Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 71. Asia Pacific Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 72. Asia Pacific Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 75. Asia Pacific Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 76. Asia Pacific Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Microbial Alternative Protein Sales by Region (2017-2022) & (Kiloton)
Table 79. Asia Pacific Microbial Alternative Protein Sales by Region (2023-2028) & (Kiloton)
Table 80. Asia Pacific Microbial Alternative Protein Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Microbial Alternative Protein Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 83. Latin America Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 84. Latin America Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 87. Latin America Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 88. Latin America Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Microbial Alternative Protein Sales by Country (2017-2022) & (Kiloton)
Table 91. Latin America Microbial Alternative Protein Sales by Country (2023-2028) & (Kiloton)
Table 92. Latin America Microbial Alternative Protein Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Microbial Alternative Protein Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Microbial Alternative Protein Sales by Type (2017-2022) & (Kiloton)
Table 95. Middle East and Africa Microbial Alternative Protein Sales by Type (2023-2028) & (Kiloton)
Table 96. Middle East and Africa Microbial Alternative Protein Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Microbial Alternative Protein Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Microbial Alternative Protein Sales by Application (2017-2022) & (Kiloton)
Table 99. Middle East and Africa Microbial Alternative Protein Sales by Application (2023-2028) & (Kiloton)
Table 100. Middle East and Africa Microbial Alternative Protein Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Microbial Alternative Protein Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Microbial Alternative Protein Sales by Country (2017-2022) & (Kiloton)
Table 103. Middle East and Africa Microbial Alternative Protein Sales by Country (2023-2028) & (Kiloton)
Table 104. Middle East and Africa Microbial Alternative Protein Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Microbial Alternative Protein Revenue by Country (2023-2028) & (US$ Million)
Table 106. AgriProtein (South Africa) Corporation Information
Table 107. AgriProtein (South Africa) Description and Major Businesses
Table 108. AgriProtein (South Africa) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 109. AgriProtein (South Africa) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. AgriProtein (South Africa) Recent Developments
Table 111. Ynsect (France) Corporation Information
Table 112. Ynsect (France) Description and Major Businesses
Table 113. Ynsect (France) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 114. Ynsect (France) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Ynsect (France) Recent Developments
Table 116. Enterra Feed Corporation (Canada) Corporation Information
Table 117. Enterra Feed Corporation (Canada) Description and Major Businesses
Table 118. Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 119. Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Enterra Feed Corporation (Canada) Recent Developments
Table 121. Protix (The Netherlands) Corporation Information
Table 122. Protix (The Netherlands) Description and Major Businesses
Table 123. Protix (The Netherlands) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 124. Protix (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Protix (The Netherlands) Recent Developments
Table 126. Proti-Farm Holding NV (The Netherlands) Corporation Information
Table 127. Proti-Farm Holding NV (The Netherlands) Description and Major Businesses
Table 128. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 129. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Proti-Farm Holding NV (The Netherlands) Recent Developments
Table 131. Entomo Farms (Canada) Corporation Information
Table 132. Entomo Farms (Canada) Description and Major Businesses
Table 133. Entomo Farms (Canada) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 134. Entomo Farms (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Entomo Farms (Canada) Recent Developments
Table 136. Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
Table 137. Global Bugs Asia Co., Ltd. (Thailand) Description and Major Businesses
Table 138. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 139. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Global Bugs Asia Co., Ltd. (Thailand) Recent Developments
Table 141. Aspire Food Group (U.S.) Corporation Information
Table 142. Aspire Food Group (U.S.) Description and Major Businesses
Table 143. Aspire Food Group (U.S.) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 144. Aspire Food Group (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Aspire Food Group (U.S.) Recent Developments
Table 146. Tiny Farms (U.S.) Corporation Information
Table 147. Tiny Farms (U.S.) Description and Major Businesses
Table 148. Tiny Farms (U.S.) Microbial Alternative Protein Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 149. Tiny Farms (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Tiny Farms (U.S.) Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Microbial Alternative Protein Distributors List
Table 154. Microbial Alternative Protein Customers List
Table 155. Microbial Alternative Protein Market Trends
Table 156. Microbial Alternative Protein Market Drivers
Table 157. Microbial Alternative Protein Market Challenges
Table 158. Microbial Alternative Protein Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Microbial Alternative Protein Product Picture
Figure 3. Global Microbial Alternative Protein Market Share by Type in 2021 & 2028
Figure 3. Emerging Alternative Protein Product Picture
Figure 4. Adolescent Alternative Protein Product Picture
Figure 5. Matured Alternative Protein Product Picture
Figure 6. Global Microbial Alternative Protein Market Share by Application in 2021 & 2028
Figure 7. Food
Figure 8. Feed
Figure 9. Others
Figure 10. Microbial Alternative Protein Report Years Considered
Figure 11. Global Microbial Alternative Protein Sales 2017-2028 (Kiloton)
Figure 12. Global Microbial Alternative Protein Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Microbial Alternative Protein Revenue 2017-2028 (US$ Million)
Figure 14. Global Microbial Alternative Protein Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Microbial Alternative Protein Sales Market Share by Region (2017-2022)
Figure 16. Global Microbial Alternative Protein Sales Market Share by Region (2023-2028)
Figure 17. North America Microbial Alternative Protein Sales YoY (2017-2028) & (Kiloton)
Figure 18. North America Microbial Alternative Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Microbial Alternative Protein Sales YoY (2017-2028) & (Kiloton)
Figure 20. Europe Microbial Alternative Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Microbial Alternative Protein Sales YoY (2017-2028) & (Kiloton)
Figure 22. Asia-Pacific Microbial Alternative Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Microbial Alternative Protein Sales YoY (2017-2028) & (Kiloton)
Figure 24. Latin America Microbial Alternative Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Microbial Alternative Protein Sales YoY (2017-2028) & (Kiloton)
Figure 26. Middle East & Africa Microbial Alternative Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Microbial Alternative Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Microbial Alternative Protein in the World: Market Share by Microbial Alternative Protein Revenue in 2021
Figure 29. Global Microbial Alternative Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 31. Global Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 32. Global Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 33. Global Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 34. North America Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 35. North America Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 36. North America Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 37. North America Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 38. North America Microbial Alternative Protein Sales Share by Country (2017-2028)
Figure 39. North America Microbial Alternative Protein Revenue Share by Country (2017-2028)
Figure 40. U.S. Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 43. Europe Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 44. Europe Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 45. Europe Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 46. Europe Microbial Alternative Protein Sales Share by Country (2017-2028)
Figure 47. Europe Microbial Alternative Protein Revenue Share by Country (2017-2028)
Figure 48. Germany Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 49. France Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Microbial Alternative Protein Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Microbial Alternative Protein Revenue Share by Region (2017-2028)
Figure 59. China Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 62. India Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 70. Latin America Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 72. Latin America Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Microbial Alternative Protein Sales Share by Country (2017-2028)
Figure 74. Latin America Microbial Alternative Protein Revenue Share by Country (2017-2028)
Figure 75. Mexico Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Microbial Alternative Protein Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Microbial Alternative Protein Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Microbial Alternative Protein Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Microbial Alternative Protein Revenue Share by Country (2017-2028)
Figure 84. Turkey Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Microbial Alternative Protein Revenue (2017-2028) & (US$ Million)
Figure 87. Microbial Alternative Protein Value Chain
Figure 88. Microbial Alternative Protein Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
